Literature DB >> 14740954

Serotype-specific T(H)1 responses in recipients of two doses of candidate live-attenuated dengue virus vaccines.

William Gwinn1, Wellington Sun, Bruce L Innis, Jeffrey Caudill, Alan D King.   

Abstract

As part of a larger vaccine study, peripheral blood mononuclear cells (PBMC) were collected from volunteers for analysis of vaccine-induced T cell responses. The PBMC were re-stimulated in vitro with live dengue virus and assayed for T(H)1 or T(H)2 memory cell responses. Re-stimulated PBMC from the volunteers predominantly secreted interferon-gamma. Little interleukin-4 (IL-4) or IL-10 secretion was detected, indicating a T(H)1 type of T cell response. The interferon-gamma response was primarily serotype-specific with some serotype cross-reactivity. T cell depletion studies showed that the interferon-gamma was being secreted by CD4+ T lymphocytes and/or by cells other than CD8+ T lymphocytes that were being stimulated by the CD4+ T lymphocytes. CD3+ or CD8+ T cell depletion showed that granzyme B mRNA expression correlated with the presence of CD4+ T lymphocytes. However, depletion of CD4+ T cells after four days of stimulation indicated that the granzyme B mRNA was produced by cells in culture other than lymphocytes. In summary, an antigen-specific T(H)1 type T cell response was seen as a response to vaccination using live attenuated dengue virus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740954     DOI: 10.4269/ajtmh.2003.69.39

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.

Authors:  Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 2.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

3.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

4.  Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.

Authors:  James S Testa; Ramila Philip
Journal:  Future Virol       Date:  2012-11-01       Impact factor: 1.831

5.  Immunopathogenesis Versus Protection in Dengue Virus Infections.

Authors:  Alan L Rothman; Carey L Medin; Heather Friberg; Jeffrey R Currier
Journal:  Curr Trop Med Rep       Date:  2014-03-01

Review 6.  The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response.

Authors:  Jacky Flipse; Jolanda M Smit
Journal:  PLoS Negl Trop Dis       Date:  2015-06-11

Review 7.  Human T Cell Response to Dengue Virus Infection.

Authors:  Yuan Tian; Alba Grifoni; Alessandro Sette; Daniela Weiskopf
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

8.  Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.

Authors:  Sarah Rowland-Jones; Tao Dong; Edward Moran; Cameron Simmons; Nguyen Vinh Chau; Kerstin Luhn; Bridget Wills; Nguyen Phuong Dung; Le Thi Thu Thao; Tran Tinh Hien; Jeremy Farrar
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

9.  Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.

Authors:  Eduardo J M Nascimento; Robbie B Mailliard; Asif M Khan; John Sidney; Alessandro Sette; Nicole Guzman; Michael Paulaitis; Andréa Barbosa de Melo; Marli T Cordeiro; Laura V G Gil; Françoir Lemonnier; Charles Rinaldo; J Thomas August; Ernesto T A Marques
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.